-+ 0.00%
-+ 0.00%
-+ 0.00%

Tonix Pharmaceuticals Unveils Phase 2/3-Ready Monoclonal Antibody for Lyme Disease Prevention

Reuters·12/29/2025 12:46:21

Please log in to view news